Nutrient Flavonoids and Lung Cancer Prevention
营养类黄酮与肺癌预防
基本信息
- 批准号:7319665
- 负责人:
- 金额:$ 10.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-15 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsApoptosisApoptoticAutomobile DrivingCancer PatientCaspaseCell Culture SystemCell DeathCellsCessation of lifeChemopreventionChemopreventive AgentDevelopmentDiagnosisDiseaseDisruptionDominant-Negative MutationElectron TransportEpithelialFamily memberFlavonoidsFutureGlutathioneGlutathione DisulfideGoalsHealthHumanIn VitroIncidenceLeadLungLuteolinMalignant NeoplasmsMalignant neoplasm of lungMediatingMitochondriaNutrientOxidoreductasePreventionPreventiveProcessProductionPropertyRateReactive Oxygen SpeciesResearchRoleSmall Interfering RNAStagingSuperoxide DismutaseSystemTestingUnited Statesbasecancer cellcaspase-8caspase-9clinical applicationcytochrome ccytotoxicityglutathione peroxidasein vivoinhibitor-of-apoptosis proteininhibitor/antagonistkillingslung cancer preventionmortalityoutcome forecastreceptorresponsestress-activated protein kinase 1success
项目摘要
DESCRIPTION (provided by applicant):
Lung cancer is a major health concern with a very high mortality rate, afflicting approximately 170,000 people each year in the United States. Because most lung cancer patients are diagnosed at a late stage of the disease and available therapies are usually ineffective, the prognosis is very poor for most lung cancer patients. Theoretically, blockage of the multiple-step process of the progression from preinvasive disease to malignancy will reduce the incidence of advanced lung cancer. Therefore, development of effective prevention agents against lung cancer is critical for reducing mortality. In this study, we will focus on the flavonoid luteolin (3',4',5,7-tetrahydroxyflavone) as a potential lung cancer chemoprevention agent. Our preliminary studies demonstrate that the flavonoid luteolin selectively kills transformed but not normal lung cells and that reactive oxygen species (ROS) accumulation is essential for the luteolin-induced cytotoxicity in lung cancer cells. To establish the basis of future studies on the activity and mechanism of luteolin in lung cancer prevention, we plan to determine the underlying mechanism by which luteolin kills lung cancer cells in an in vitro cell culture system. The hypothesis driving this application is that luteolin-induced ROS mediates activation of c-Jun N- terminal kinase (JNK), which subsequently triggers activation of apoptosis pathways in transformed lung cells. This activation of apoptosis contributes to the chemopreventive activity of luteolin against lung cancer. We will test this hypothesis in the following specific aims: 1) to determine the mechanism by which luteolin induces ROS accumulation in lung cancer cells, 2) to determine the mechanism by which luteolin induces apoptosis in lung cancer cells, and 3) to determine the mechanism of selective cytotoxicity of luteolin in lung cancer cells. The success of this project would lead to development of future studies in animals and humans to test the preventive activity and mechanism of luteolin against lung cancer in vivo, which may lead to the clinical application of luteolin for human lung cancer prevention.
描述(由申请人提供):
肺癌是一个主要的健康问题,具有非常高的死亡率,在美国每年约有170,000人受到折磨。由于大多数肺癌患者在疾病的晚期被诊断出来,并且可用的治疗通常无效,因此大多数肺癌患者的预后非常差。从理论上讲,阻断癌前病变发展为恶性肿瘤的多步骤过程将降低晚期肺癌的发病率。因此,开发有效的肺癌预防药物对降低死亡率至关重要。在本研究中,我们将重点关注黄酮类化合物木樨草素(3 ',4',5,7-四羟基黄酮)作为一种潜在的肺癌化学预防剂。我们的初步研究表明,黄酮类化合物木犀草素选择性地杀死转化,但不是正常的肺细胞和活性氧(ROS)的积累是必不可少的木犀草素诱导的细胞毒性在肺癌细胞。为进一步研究木犀草素在肺癌预防中的活性和机制奠定基础,我们计划在体外细胞培养系统中确定木犀草素杀死肺癌细胞的潜在机制。驱动该应用的假设是木犀草素诱导的ROS介导c-Jun N-末端激酶(JNK)的活化,其随后触发转化的肺细胞中的凋亡途径的活化。这种细胞凋亡的激活有助于毛地黄黄酮对肺癌的化学预防活性。我们将在以下具体目标中检验这一假设:1)确定木犀草素诱导肺癌细胞中ROS积累的机制,2)确定木犀草素诱导肺癌细胞凋亡的机制,和3)确定木犀草素在肺癌细胞中选择性细胞毒性的机制。该项目的成功将导致未来在动物和人类中开展研究,以测试木犀草素对肺癌的预防活性和体内机制,这可能导致木犀草素用于人类肺癌预防的临床应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yong Lin其他文献
Yong Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yong Lin', 18)}}的其他基金
Targeting RIP3-mediated Necroptosis for Chemosensitization
针对 RIP3 介导的坏死性凋亡进行化疗增敏
- 批准号:
9251788 - 财政年份:2016
- 资助金额:
$ 10.25万 - 项目类别:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
MUC1 桥接炎症和香烟烟雾相关的肺癌发生
- 批准号:
8434940 - 财政年份:2010
- 资助金额:
$ 10.25万 - 项目类别:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
MUC1 桥接炎症和香烟烟雾相关的肺癌发生
- 批准号:
7986321 - 财政年份:2010
- 资助金额:
$ 10.25万 - 项目类别:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
MUC1 桥接炎症和香烟烟雾相关的肺癌发生
- 批准号:
8240086 - 财政年份:2010
- 资助金额:
$ 10.25万 - 项目类别:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
MUC1 桥接炎症和香烟烟雾相关的肺癌发生
- 批准号:
8641691 - 财政年份:2010
- 资助金额:
$ 10.25万 - 项目类别:
Bridging Inflammation and Cigarette Smoke-associated Lung Carcinogenesis by MUC1
MUC1 桥接炎症和香烟烟雾相关的肺癌发生
- 批准号:
8125009 - 财政年份:2010
- 资助金额:
$ 10.25万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10596657 - 财政年份:2021
- 资助金额:
$ 10.25万 - 项目类别:
Spatial Restriction of Apoptotic Machinery during Neuronal Apoptosis and Pruning
神经元凋亡和修剪过程中凋亡机制的空间限制
- 批准号:
10417219 - 财政年份:2021
- 资助金额:
$ 10.25万 - 项目类别:
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2015
- 资助金额:
$ 10.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2014
- 资助金额:
$ 10.25万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Understanding the activation of pro-apoptotic Bcl-2 family proteins for the development of modulators of apoptosis
了解促凋亡 Bcl-2 家族蛋白的激活以开发凋亡调节剂
- 批准号:
nhmrc : 1059331 - 财政年份:2014
- 资助金额:
$ 10.25万 - 项目类别:
Project Grants
Examining the contribution of apoptosis repressor with caspase recruitment domain (ARC) to the anti-apoptotic effect of endurance training in skeletal muscle
检查具有半胱天冬酶募集结构域 (ARC) 的凋亡抑制因子对骨骼肌耐力训练的抗凋亡作用的贡献
- 批准号:
441952-2013 - 财政年份:2013
- 资助金额:
$ 10.25万 - 项目类别:
Postgraduate Scholarships - Doctoral
Apoptotic Osteocytes Promote Chondrocyte Apoptosis via Soluble Factors
凋亡骨细胞通过可溶性因子促进软骨细胞凋亡
- 批准号:
251802 - 财政年份:2012
- 资助金额:
$ 10.25万 - 项目类别:
Studentship Programs
Defining the mechanism(s) by which the cellular inhibitor of apoptosis protein 2 (cIAP2) contributes to early stage atherosclerosis development by directly promoting the participation of key apoptotic pathways within lesion-associated macrophages
确定凋亡蛋白细胞抑制剂 2 (cIAP2) 通过直接促进病变相关巨噬细胞内关键凋亡途径的参与来促进早期动脉粥样硬化发展的机制
- 批准号:
191299 - 财政年份:2009
- 资助金额:
$ 10.25万 - 项目类别:
Operating Grants
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
8075522 - 财政年份:2009
- 资助金额:
$ 10.25万 - 项目类别:
ATP release during apoptosis and its relevance to apoptotic cell clearance
凋亡过程中 ATP 释放及其与凋亡细胞清除的相关性
- 批准号:
7676912 - 财政年份:2009
- 资助金额:
$ 10.25万 - 项目类别: